sur BIOSYNEX (EPA:ALBIO)
BIOSYNEX SA unveils its financial calendar for 2026
BIOSYNEX SA, a specialist in healthcare diagnostics, has published its 2026 financial calendar. The group, known for its rapid tests and expertise in molecular biology, has announced key dates for the coming year. Revenue for 2025 will be released on January 15, 2026, followed by the annual results on April 22. First-half revenue will be announced on July 22, and the first-half results are expected on October 21. These announcements will follow market close.
Founded in 2005, BIOSYNEX is recognized for its innovative solutions for laboratories, hospitals, and the general public. The group employs over 450 people and operates in 95 countries, maintaining a strong position on Euronext Growth Paris.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de BIOSYNEX